DOI: 10.21276/ajptr
Wed, 27 Mar 2019

A Comprehensive Review on Progeria

Srikrishna.T*1, S.Srividya1, B.Prasanth Kumar1, B.Jonathan Wilson1,

P.Sudheer Kumar1, T.Praveen Kumar1

1.Department of Pharmaceutics, Narayana Pharmacy College, Chinthareddypalem,

 Nellore, SPSR Nellore District, Andhra Pradesh, India.


Our life span is genetically programmed and it is possible that a defect in produced proteins encoded by the ‘longevity’ gene is a cause of aging. Progeria which is a rare, fatal genetic condition which affects between one in four million and one in eight million children of both sexes equally and characterized by premature and accelerated aging. The appearance and physiology of these children resembles to elderly people but they typically have life span to their mid teens. It is also known as the Hutchinson-Gilford syndrome, which was initially reported by Johnathan Hutchinson in 1886 and further described by Hastings Gilford in 1904. It is an autosomal recessive disorder, which means an individual has inherited a mutated gene from both parents. It is added to the expanding catalogue of ‘laminopathies’, diseases caused by mutations affecting nuclear lamina proteins known as lamin A (LMNA). Currently, there are about 50 known cases of Progeria in the world and most Progeria patients die at around 13 years of age. Treatment usually includes aspirin which helps prevent the atherothrombotic events, stroke and heart attacks by hindering platelet aggregation. Vitamin supplementation, Fluoride supplements are recommended. A Study of Zoledronic acid, Pravastatin, and Lonafarnib for Patients with Progeria is ongoing, it is under phase II.

Keywords: Progeria, Hutchinson Gilford Progeria Syndrome, Premature Aging, Aspirin, Atherothrombotic, lamin A.

[PDF]   Viewed: 883   Downloaded: 173
  • Call for paper

    American Journal of PharmTech Research (AJPTR) is a peer-reviewed, bimonthly official international journal allowing access to abstracts and full-text.



  • Email & SMS Alerts

    Email/SMS alert system is one of the key features and gives update information about the submitted manuscript.


  • Article Statastics

    American Journal of PharmTech Research (AJPTR) provides unique facility for authors to know popularity of articles on basis of numbers of PDF download and views. It will display in tabulated format.

  • Online Submission

    American Journal of PharmTech Research (AJPTR) is one of the International open access journal devoted to various disciplines in science and technology.


web counter
web counter